Source: International Business Times
US President Donald Trump speaks during an event about weight-loss drugs in the Oval Office of the White House in Washington, DC on November 6, 2025. President Donald Trump announced Thursday a new initiative called "TrumpRx" aimed at lowering the cost of popular weight-loss drugs Wegovy and Zepbound, in deals with pharmaceutical companies Novo Nordisk and Eli Lilly. The program seeks to make these treatments more affordable for millions of Americans struggling with obesity.
Aller á la Source
Nouvelles connexes
